2 results
Approved WMOCompleted
To assess the anti-tumor activity of LGX818/MEK162 in combination with third targeted agents after progression on LGX818/MEK162 combination therapy.
Approved WMOCompleted
To assess the feasibility of implantation of CRT devices via a combined transvenous and epicardial procedure in patients with an unfavourable coronary venous anatomy. In addition, the safety of the procedure will be assessed in preparation for a…